IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 161 - 180 of 1231 stories.
June 9, 2014
ScinoPharm (Tainan, Taiwan), a company that develops and manufactures active pharmaceutical ingredients (APIs), says that it has signed a manufacturing contract with TaiGen...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/ScinoPharm-and-TaiGen-sign-API-manufacturing-deal_61619.html
June 5, 2014
After assessing of Ranbaxy Laboratories' (Gurgaon, India) active pharmaceutical ingredient (API) manufacturing facility at Toansa, India, European regulatory authorities say...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/European-regulatory-authorities-to-reinstate-GMP-certificate-for-Ranbaxys-API-plant-at-Toansa_61581.html
June 4, 2014
Lubrizol says that its life science polymers business has introduced a new pharmaceutical-grade excipient, Pathway. As pharmaceutical companies face the challenge of the patent cliff...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lubrizol-introduces-a-new-pharmaceutical-excipient_61540.html
June 3, 2014
FDA scaling back API facility inspections in US; Socma asks FDA to ensure frequency of inspections does not exceed three years The Bulk Pharmaceuticals Task Force (BPTF), an affiliate...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-3-June-2014_61507.html
May 27, 2014
Pfizer confirmed today that its “informal” offer to acquire AstraZeneca for £69.4 billion (117 billion) has lapsed and that it was consequently withdrawing the offer...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-walks-away-from-AstraZeneca-bid_61321.html
May 27, 2014
FDA issues warning letter to Sun Pharma's API plant in India FDA issued a warning letter on 7 May to the active pharmaceutical ingredient (API) and finished pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-27-May-2014_61323.html
May 22, 2014
Novasep (Pompey, France), a supplier of services and technologies to the life sciences industry, says that it has completed a €4-million ($5.5 million) expansion of its highly...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novasep-completes-expansion-of-HPAPI-capacity-in-France_61222.html
May 21, 2014
FDA issued a warning letter on 7 May to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facilities of Sun Pharmaceutical Industries (Sun Pharma...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-to-Sun-Pharmas-API-plant-in-India_61187.html
May 20, 2014
SAFC Commercial, the custom manufacturing services business unit of Sigma-Aldrich, has installed a new commercial-scale continuous-flow reactor at its Sheboygan, WI, facility with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SAFC-expands-continuous-flow-capabilities_61163.html
May 20, 2014
AstraZeneca rejects Pfizer's latest offer AstraZeneca has rejected Pfizer's latest offer to buy AstraZeneca. Pfizer says its offer, which values AstraZeneca at £69 billion ($116...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-20-May-2014_61166.html
May 20, 2014
Pharmaceutical company Relypsa (Redwood City, CA) says that it has entered into a multi-year commercial manufacturing and supply agreement with DSM Fine Chemicals for the active...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-Fine-Chemicals-and-Relypsa-sign-API-manufacturing-agreement_61165.html
May 19, 2014
Abbott Laboratories said on Friday that it has signed a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals (Santiago), more than doubling the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Abbott-to-acquire-Latin-American-generic-drugs-producer-CFR-for-$3-billion_61119.html
May 19, 2014
Pfizer said on Sunday that it has raised its offer for AstraZeneca to £69 billion ($116 billion), and said it would walk away if AstraZeneca does not accept the offer. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pfizer-makes-final-offer-for-AstraZeneca-will-walk-away-if-offer-not-accepted_61125.html
May 13, 2014
Specialty chemicals and food ingredients distributor IMCD Group (Rotterdam) says that it has signed an agreement to acquire the agency business of Jucker Pharma (Stockholm), a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/IMCD-acquires-Swedish-distributor-of-pharma-ingredients_61021.html
May 13, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) reports a 6.7% fall in...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-13-May-2014_61025.html
May 10, 2014
Merck KGaA (Darmstadt, Germany) plans to invest €100 million ($137.6 million) this year in biosimilars, a new business being developed by its Merck Serono unit. In addition, Merck...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-to-invest-in-biosimilars-eyes-pharma-acquisitions_60979.html
May 8, 2014
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, reports a net loss of $6.37 million in the first quarter of 2014 compared...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Codexis-narrows-loss_60892.html
May 6, 2014
The oral solid-dosage form (OSDF) excipients market, which is valued at nearly $2.3 billion in the United States, Europe, India, and China, is growing sustainably on a global scale...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Study-Oral-solid-dosage-form-excipients-market-growing-at-7-4-percentyear_60818.html
May 6, 2014
Cambrex reports huge fall in profits Cambrex (East Rutherford, NJ) reports a 91.2% fall in net profits for the first quarter of 2014 compared with the year-ago period, to $982,000...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-6-May-2014_60821.html
Pages: « Previous  1 2 3 4 5 6 7 8 [9] 10 11 12 13 14 15 16 17 18 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa